Condition: Renal Diseases · Cerebral Disorder · Sponsor: Mario Negri Institute for Pharmacological Research
This is a single-center observational study aimed at setting up and testing new ultrasound vascular imaging protocols, conducted exclusively for research purposes. The study will perform US examinations in 60 subjects. The subjects enrolled in the study will be examined the first time and will then provide consent to be examined again in the future if needed. The primary aim of this study is to set-up and test new advanced US protocol for the arm and cerebral blood vessels The secondary objectives will be: * Define ranges of normality/reference values of US-based parameters to be compared with pathological values. * Evaluate the repeatability and reproducibility of the acquired US measurements. * Evaluate the correlation between age and the acquired US measurements. * Evaluate the correlation between gender and the acquired US measurements.
This description comes directly from the study's public registry record.
Michela Bozzetto, Ph.D. · +39 035 4535 381 · michela.bozzetto@marionegri.it
Luca Soliveri · +39 035 4535 381 · luca.soliveri@marionegri.it
Always discuss trial participation with your own doctor first.
| Clinical Research Centre for Rare Diseases Aldo e Cele Daccò | Ranica, BG, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06841887